ATS 2019:肺部和重症监护室中诊断真菌感染微生物实验室检测

2019-09-27 美国胸科学会 Am J Respir Crit Care Med Vol 200, Iss 5, pp 535–5

背景:真菌感染在免疫功能低下和有免疫能力的患者中的发病率和重要性不断增加。方法:对侵袭性肺曲霉菌病,侵袭性念珠菌病和常见地方性霉菌病的诊断相关文献进行适当的回顾。在适当的时候进行荟萃分析。结果:该指南包括有关在血清和BAL中使用半乳甘露聚糖检测以及诊断浸润性肺曲霉病,PCR在诊断浸润性肺曲霉病中的作用, b-D-葡聚糖检测在侵袭性念珠菌病诊断中的作用以及血清学和抗原检测在地方性真菌病诊断中的应用。

中文标题:

ATS 2019:肺部和重症监护室中诊断真菌感染微生物实验室检测

英文标题:

Microbiological Laboratory Testing in the Diagnosis of FungalInfections in Pulmonary and Critical Care Practice

发布机构:

美国胸科学会

发布日期:

2019-09-27

简要介绍:

背景:真菌感染在免疫功能低下和有免疫能力的患者中的发病率和重要性不断增加。方法:对侵袭性肺曲霉菌病,侵袭性念珠菌病和常见地方性霉菌病的诊断相关文献进行适当的回顾。在适当的时候进行荟萃分析。结果:该指南包括有关在血清和BAL中使用半乳甘露聚糖检测以及诊断浸润性肺曲霉病,PCR在诊断浸润性肺曲霉病中的作用, b-D-葡聚糖检测在侵袭性念珠菌病诊断中的作用以及血清学和抗原检测在地方性真菌病诊断中的应用。结论:快速,准确地诊断真菌感染取决于实验室检测的正确应用,包括抗原检测,血清学测试和基于PCR的检测。

相关资料下载:
[AttachmentFileName(sort=100, fileName=ATS 2019:肺部和重症监护室中诊断真菌感染微生物实验室检测)] GetToolGuiderByIdResponse(projectId=1, id=f64a41c001e966cb, title=ATS 2019:肺部和重症监护室中诊断真菌感染微生物实验室检测, enTitle=Microbiological Laboratory Testing in the Diagnosis of FungalInfections in Pulmonary and Critical Care Practice, guiderFrom=Am J Respir Crit Care Med Vol 200, Iss 5, pp 535–5, authorId=null, author=, summary=背景:真菌感染在免疫功能低下和有免疫能力的患者中的发病率和重要性不断增加。方法:对侵袭性肺曲霉菌病,侵袭性念珠菌病和常见地方性霉菌病的诊断相关文献进行适当的回顾。在适当的时候进行荟萃分析。结果:该指南包括有关在血清和BAL中使用半乳甘露聚糖检测以及诊断浸润性肺曲霉病,PCR在诊断浸润性肺曲霉病中的作用, b-D-葡聚糖检测在侵袭性念珠菌病诊断中的作用以及血清学和抗原检测在地方性真菌病诊断中的应用。, cover=, journalId=null, articlesId=null, associationId=181, associationName=美国胸科学会, associationIntro=null, copyright=0, guiderPublishedTime=Fri Sep 27 03:53:25 CST 2019, originalUrl=, linkOutUrl=, content=背景:真菌感染在免疫功能低下和有免疫能力的患者中的发病率和重要性不断增加。方法:对侵袭性肺曲霉菌病,侵袭性念珠菌病和常见地方性霉菌病的诊断相关文献进行适当的回顾。在适当的时候进行荟萃分析。结果:该指南包括有关在血清和BAL中使用半乳甘露聚糖检测以及诊断浸润性肺曲霉病,PCR在诊断浸润性肺曲霉病中的作用, b-D-葡聚糖检测在侵袭性念珠菌病诊断中的作用以及血清学和抗原检测在地方性真菌病诊断中的应用。结论:快速,准确地诊断真菌感染取决于实验室检测的正确应用,包括抗原检测,血清学测试和基于PCR的检测。, tagList=[TagDto(tagId=15190, tagName=真菌感染)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3025, appHits=355, showAppHits=9, pcHits=1630, showPcHits=1960, likes=45, shares=15, comments=4, approvalStatus=1, publishedTime=Fri Sep 27 03:53:25 CST 2019, publishedTimeString=2019-09-27, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=fbzhang, createdTime=Fri Sep 27 03:53:25 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 13:37:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=ATS 2019:肺部和重症监护室中诊断真菌感染微生物实验室检测)])
ATS 2019:肺部和重症监护室中诊断真菌感染微生物实验室检测
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1207132, encodeId=2259120e13210, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:48:13 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996966, encodeId=57e499696627, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c701739589, createdName=lily241, createdTime=Wed Jul 07 03:20:46 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906083, encodeId=272f90608332, content=这个是重要学习材料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=彧日东升, createdTime=Tue Dec 08 17:18:11 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2022-03-30 洁巴子

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1207132, encodeId=2259120e13210, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:48:13 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996966, encodeId=57e499696627, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c701739589, createdName=lily241, createdTime=Wed Jul 07 03:20:46 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906083, encodeId=272f90608332, content=这个是重要学习材料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=彧日东升, createdTime=Tue Dec 08 17:18:11 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2021-07-07 lily241

    很好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1207132, encodeId=2259120e13210, content=学习了 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211220/34dc3395cbdc499d89c489c063269dd6/050ea6ea2df143eaa7f141a7ebb4d0bc.jpg, createdBy=94156413226, createdName=洁巴子, createdTime=Wed Mar 30 09:48:13 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996966, encodeId=57e499696627, content=很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6c701739589, createdName=lily241, createdTime=Wed Jul 07 03:20:46 CST 2021, time=2021-07-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=906083, encodeId=272f90608332, content=这个是重要学习材料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210826/7a6cce5e03844bcf8a6ee8a36dba8188/b15bf50504094d3aa56a8f1a32d3304c.jpg, createdBy=1d8c1533153, createdName=彧日东升, createdTime=Tue Dec 08 17:18:11 CST 2020, time=2020-12-08, status=1, ipAttribution=)]
    2020-12-08 彧日东升

    这个是重要学习材料

    0